Who owns the THE GENE TO ANTIBODY COMPANY trademark?

The THE GENE TO ANTIBODY COMPANY trademark is owned by Genovac Antibody Discovery LLC.

What class is the THE GENE TO ANTIBODY COMPANY trademark registered in?

The THE GENE TO ANTIBODY COMPANY trademark is registered in Class 040 (Treatment & processing of materials), Class 042 (Scientific, technology & SaaS services).

What is the serial number for THE GENE TO ANTIBODY COMPANY?

The USPTO serial number for THE GENE TO ANTIBODY COMPANY is 97382404.

What is the registration number for THE GENE TO ANTIBODY COMPANY?

THE GENE TO ANTIBODY COMPANY is registered under USPTO registration number 7264779.

THE

USPTO Trademark Record

REGISTERED

THE GENE TO ANTIBODY COMPANY

SN 97382404·Reg 7264779·Filed Apr 26, 2022

Owner Genovac Antibody Discovery LLC

Treatment of materials; recycling of waste and trash; air purification and treatment of water; printing services; food and drink preservation.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

THE GENE TO ANTIBODY COMPANY (Serial No. 97382404), Registration No. 7264779, is a registered US trademark filed on Apr 26, 2022 by Genovac Antibody Discovery LLC. This trademark covers Class 040 (Treatment & processing of materials), Class 042 (Scientific, technology & SaaS services).

early section 8: January 02, 2030

Mark Intelligence

THE GENE TO ANTIBODY COMPANY (Reg. #7264779) is a registered US trademark that has been protecting its owner, Genovac Antibody Discovery LLC, since 2022. The mark covers Class 040 (Treatment & processing of materials) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Treatment of materials; recycling of waste and trash; air purification and treatment of water; printing services; food a....

FILED

Apr 26, 2022

SERIAL

97382404

REG#

7264779

REGISTERED

Jan 02, 2024

Owner

Applicant

Genovac Antibody Discovery LLC

Entity

LLC

State

Address

1810 NDSU Research Circle N, Ste B, Fargo, ND, 58102

Country

Attorney

NameThomas Kading

Law firm

Thomas Kading FARGO PATENT AND BUSINESS LAW, PLLC

Docket

01515-GEN

Address

2605 42ND ST. S, 2605 42ND ST. S, FARGO, ND 58104, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 26, 2022

Serial Number97382404

Registration No.7264779

Registration DateJan 02, 2024

Status DateJan 02, 2024

Mark TypeStandard characters

Attorney Docket01515-GEN

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 040Treatment & processing of materials

US codes: 100, 103, 106

First use anywhere: Nov 01, 2020

First use in commerce: Nov 01, 2020

Treatment of materials; recycling of waste and trash; air purification and treatment of water; printing services; food and drink preservation.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 01, 2020

First use in commerce: Nov 01, 2020

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

REGISTERED-SUPPLEMENTAL REGISTER

Jan 02, 2024

REGISTERED-SUPPLEMENTAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 02, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

EXAMINERS AMENDMENT -WRITTEN

Apr 26, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 26, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 26, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 26, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Apr 26, 2023

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 15, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 14, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 14, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Feb 21, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 21, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 21, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 13, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 02, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 29, 2022

NEW APPLICATION ENTERED

THE GENE TO ANTIBODY COMPANY

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Genovac Antibody Discovery LLC

Other Marks in Class 040 — Treatment & processing of materials

Other Marks by Thomas Kading

Resources

Company